Research & Innovation

SFI and Pfizer are pleased to announce a webinar to present the SFI-Pfizer Biotherapeutics Innovation Award Programme 2014

The SFI-Pfizer Biotherapeutics Innovation Award Programme (BIAP) 2014 provides a unique opportunity for eligible academic biomedical investigators to combine cutting-edge biology with Pfizer’s drug discovery and development platforms and expertise. The purpose of each collaborative project will be to identify potential biopharmaceutical candidates directed at novel disease targets or pathways of interest which are suitable to modulation by a biologic or antibody-drug conjugate.

Further information on the SFI-Pfizer Biotherapeutics Innovation Award Programme 2014 can be found here.

Webinar – Tuesday 4th March 2014, 15:00 – 16:00 GMT

SFI and Pfizer will jointly host a webinar on Tuesday 4th March from 15:00 – 16:00 GMT to discuss the main points of the SFI-Pfizer Biotherapeutics Innovation Award Programme 2014.  The call will be officially launched by March 3rd 2014. Participation is advised for all potential applicants.

Space is limited. To register for the webinar, please click here.